Cite
CEP-11004, an inhibitor of the SAPK/JNK pathway, reduces TNF-alpha release from lipopolysaccharide-treated cells and mice.
MLA
Ciallella, John R., et al. “CEP-11004, an Inhibitor of the SAPK/JNK Pathway, Reduces TNF-Alpha Release from Lipopolysaccharide-Treated Cells and Mice.” European Journal of Pharmacology, vol. 515, no. 1–3, May 2005, pp. 179–87. EBSCOhost, https://doi.org/10.1016/j.ejphar.2005.04.016.
APA
Ciallella, J. R., Saporito, M., Lund, S., Leist, M., Hasseldam, H., McGann, N., Smith, C. S., Bozyczko-Coyne, D., & Flood, D. G. (2005). CEP-11004, an inhibitor of the SAPK/JNK pathway, reduces TNF-alpha release from lipopolysaccharide-treated cells and mice. European Journal of Pharmacology, 515(1–3), 179–187. https://doi.org/10.1016/j.ejphar.2005.04.016
Chicago
Ciallella, John R, Michael Saporito, Soren Lund, Marcel Leist, Henrik Hasseldam, Natalie McGann, Charles S Smith, Donna Bozyczko-Coyne, and Dorothy G Flood. 2005. “CEP-11004, an Inhibitor of the SAPK/JNK Pathway, Reduces TNF-Alpha Release from Lipopolysaccharide-Treated Cells and Mice.” European Journal of Pharmacology 515 (1–3): 179–87. doi:10.1016/j.ejphar.2005.04.016.